Munafa Stock Market Course + Intraday & FNO calls 
Summit Therapeutics (SMMT) Technical (Analysis) Reports Summit Therapeutics ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com
Complete & easy to understand technical analysis of Summit Therapeutics (SMMT)
Technical Analysis Report for USA stock SMMT Summit Therapeutics. Dated: 03 Jun 2026 Updated Daily. Stock trades under Health Care Deals in Major Pharmaceuticals in USA stock exchange
If you are looking for Tomorrow's Movement Predictions for USA stock SMMT Summit Therapeutics then click here. or read Experts views on Summit Therapeutics or Forecast & share price targets of Summit Therapeutics
Summit Therapeutics Opened at 14.71 and Closed at: 15.08, which is 1.46% of previous session's close. It moved within a range of 14.27 and 15.11
The session was a Bullish session with an average volume of 2798022, which is -187.68% of previous session's volumes.
- Even though the stock has shown an up move, but the short term trend of the stock remains negative and in a downtrend.
- Even though the stock has shown an up move, but the long term trend of the stock remains negative and in a downtrend.
Support for tomorrow is 14.68 and resistance for tomorrow is 15.52
These support and resistance points are valid for the first 5-15 minutes charts
Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.
Support for tomorrow's hourly charts is 14.53, 13.98 resistance for tomorrow's hourly charts is 15.37, 15.66
10 Day SMA for Summit Therapeutics (SMMT) is 16.7 and stock is trading below these levels. This is not a good sign for its short term trend
20 Day SMA for Summit Therapeutics (SMMT) is 17.17 and the stock is trading below these levels. This is not a good sign for its mid term trend
50 Day SMA for Summit Therapeutics (SMMT) is 19.02 and the stock is trading below these levels. This is not a good sign for its mid to long term trend
100 Day SMA is 17.41 and the stock is trading below these levels. This is not a good sign for its long term trend
200 Day SMA Summit Therapeutics is 18.58 and stock is trading below these levels. This is not a good sign for its long term trend
20 DMA of Summit Therapeutics is at 17.17 and 200 DMA is at 18.58, while 50 DMA and 100 DMA are at 19.02 and 17.41 respectively
Summit Therapeutics (SMMT) moving average of 20 SMA is at 17.17 and 20 EMA is at 17.17
| Date | Closing Price | 20 SMA | 20 EMA |
| 03 Wed Jun | 15.08 | 17.17 | 17.17 |
| 02 Tue Jun | 14.86 | 17.31 | 17.39 |
| 01 Mon Jun | 15.71 | 17.44 | 17.66 |
| 29 Fri May | 17.54 | 17.5 | 17.86 |
| 28 Thu May | 17.41 | 17.43 | 17.89 |
| 27 Wed May | 17.35 | 17.63 | 17.94 |
Summit Therapeutics (SMMT) moving average of 50 SMA is at 19.02 and 50 EMA is at 17.92
| Date | Closing Price | 50 SMA | 50 EMA |
| 03 Wed Jun | 15.08 | 19.02 | 17.92 |
| 02 Tue Jun | 14.86 | 19.03 | 18.04 |
| 01 Mon Jun | 15.71 | 19.05 | 18.17 |
| 29 Fri May | 17.54 | 19.04 | 18.27 |
| 28 Thu May | 17.41 | 19.01 | 18.3 |
| 27 Wed May | 17.35 | 18.98 | 18.34 |
Summit Therapeutics (SMMT) moving average of 100 SMA is at 17.41 and 100 EMA is at 18.09
| Date | Closing Price | 100 SMA | 100 EMA |
| 03 Wed Jun | 15.08 | 17.41 | 18.09 |
| 02 Tue Jun | 14.86 | 17.45 | 18.15 |
| 01 Mon Jun | 15.71 | 17.49 | 18.22 |
| 29 Fri May | 17.54 | 17.52 | 18.27 |
| 28 Thu May | 17.41 | 17.52 | 18.28 |
| 27 Wed May | 17.35 | 17.52 | 18.3 |
Summit Therapeutics (SMMT) moving average of 200 SMA is at 18.58 and 200 EMA is at 18.61
| Date | Closing Price | 200 SMA | 200 EMA |
| 03 Wed Jun | 15.08 | 18.58 | 18.61 |
| 02 Tue Jun | 14.86 | 18.64 | 18.65 |
| 01 Mon Jun | 15.71 | 18.7 | 18.69 |
| 29 Fri May | 17.54 | 18.75 | 18.72 |
| 28 Thu May | 17.41 | 18.8 | 18.73 |
| 27 Wed May | 17.35 | 18.84 | 18.74 |
Summit Therapeutics has performed better than U S in short term. Holding Summit Therapeutics could be a better choice for now!
Novartis Ag has performed better than Summit Therapeutics in short term. You could have earned much better returns by investing in Novartis Ag, about 12.35% more returns!
Iqvia Holdings has performed better than Summit Therapeutics in short term. You could have earned much better returns by investing in Iqvia Holdings, about 18.68% more returns!
Humana Inc has performed better than Summit Therapeutics in short term. You could have earned much better returns by investing in Humana Inc, about 48.49% more returns!
Edwards Lifesciences has performed better than Summit Therapeutics in short term. You could have earned much better returns by investing in Edwards Lifesciences, about 18.9% more returns!
Baxter International has performed better than Summit Therapeutics in short term. You could have earned much better returns by investing in Baxter International, about 24.71% more returns!
Abbvie Inc has performed better than Summit Therapeutics in short term. You could have earned much better returns by investing in Abbvie Inc, about 21.42% more returns!
Summit Therapeutics has performed better than Tonix Pharmaceuticals in short term. Holding Summit Therapeutics could be a better choice for now!
Merit Medical has performed better than Summit Therapeutics in short term. You could have earned much better returns by investing in Merit Medical, about 13.93% more returns!
Summit Therapeutics has performed better than Lemaitre Vascular in short term. Holding Summit Therapeutics could be a better choice for now!
Summit Therapeutics has performed better than Kiniksa Pharmaceuticals in short term. Holding Summit Therapeutics could be a better choice for now!
Summit Therapeutics has performed better than Insmed Inc in short term. Holding Summit Therapeutics could be a better choice for now!
Halozyme Therapeutics has performed better than Summit Therapeutics in short term. You could have earned much better returns by investing in Halozyme Therapeutics, about 20.75% more returns!
Dexcom Inc has performed better than Summit Therapeutics in short term. You could have earned much better returns by investing in Dexcom Inc, about 36.08% more returns!
Axsome Therapeutics has performed better than Summit Therapeutics in short term. You could have earned much better returns by investing in Axsome Therapeutics, about 20.4% more returns!
Summit Therapeutics has performed better than Assembly Biosciences in short term. Holding Summit Therapeutics could be a better choice for now!
Array Biopharma has performed better than Summit Therapeutics in short term. You could have earned much better returns by investing in Array Biopharma, about 22.9% more returns!
Align Technology has performed better than Summit Therapeutics in short term. You could have earned much better returns by investing in Align Technology, about 8.49% more returns!
Agios Pharmaceuticals has performed better than Summit Therapeutics in short term. You could have earned much better returns by investing in Agios Pharmaceuticals, about 18.11% more returns!
Summit Therapeutics Technical analysis of indicators
Price action analysis of Summit Therapeutics (SMMT) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Summit Therapeutics stock for short term is SELL. Signal strength is Strong and stock is losing momentum.
MACD generated a SELL signal for Summit Therapeutics in short term and the sell signal is strong.
Summit Therapeutics Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are getting stronger in this stock.
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be moving up
CCI has generated a SELL signal for Summit Therapeutics in short term and SELL signal is strong!
RSI is generating a SELL signal in short term and selling is picking up momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Summit Therapeutics is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 16.29 and Summit Therapeutics SMMT stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Summit Therapeutics SMMT stock. Volume based technical analysis of Summit Therapeutics SMMT stock is negative.
Summit Therapeutics Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Tomorrow's Predictions
You should also read Tomorrow's Movement Predictions for USA stock SMMT Summit Therapeutics These predictions are based on various factors, are easy to understand, and upto 75% accurate!
And SMMT Experts View which covers a lot of information including buying and selling signals
SMMT future forecast & share price targets
You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Summit Therapeutics or View Candle Stick Charts here
Quick Charts: Renko Point & Figure Just IntraDay All Indicators Weekly Monthly All in One Eagle View MACD & ADX
Videos related to: Summit Therapeutics (SMMT) Technical (Analysis) Reports Summit Therapeutics ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com
Hindi Video Correct Way Of Technical Analysis How To Find Entry Exit Points On Charts
Hindi Video Most Important Stock Market Video. No Success Without This Formula
- USA Screeners
- USA Daily Screener
- USA Weekly Screener
- USA Monthly Screener
- Support & Resistance
- USA Shares Near Support
- USA Shares Near Resistance
